0.71
-0.079(-10.06%)
Currency In USD
| Previous Close | 0.79 |
| Open | 0.77 |
| Day High | 0.8 |
| Day Low | 0.7 |
| 52-Week High | 6.15 |
| 52-Week Low | 0.52 |
| Volume | 365,210 |
| Average Volume | 1.78M |
| Market Cap | 8.07M |
| PE | -0.26 |
| EPS | -2.72 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.76 |
| Change | -0.08 |
If you invested $1000 in Mangoceuticals, Inc. (MGRX) since IPO date, it would be worth $11.77 as of January 14, 2026 at a share price of $0.706. Whereas If you bought $1000 worth of Mangoceuticals, Inc. (MGRX) shares 2 years ago, it would be worth $149.58 as of January 14, 2026 at a share price of $0.706.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
GlobeNewswire Inc.
Dec 19, 2025 3:38 PM GMT
DALLAS, TX, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands
Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy
GlobeNewswire Inc.
Dec 19, 2025 12:30 PM GMT
MULTI-DAT Framework Drives Diversified Crypto Expansion and Volatility Hedging DALLAS, TX, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of h
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
GlobeNewswire Inc.
Dec 18, 2025 1:30 PM GMT
DALLAS, TX, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands